Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Works matching IS 15268209 AND DT 2010 AND VI 10 AND IP 2
Results: 13
1
2
Characteristics, Treatment, and Outcome of Breast Cancers Diagnosed in BRCA1 and BRCA2 Gene Mutation Carriers in Intensive Screening Programs Including Magnetic Resonance Imaging.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
Integrating Bevacizumab Into the Treatment of Patients With Early-Stage Breast Cancer: Focus on Cardiac Safety.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 119, doi. 10.3816/CBC.2010.n.016
- By:
- Publication type:
- Article
4
Clinical Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 100
- By:
- Publication type:
- Article
5
Characteristics, Treatment, and Outcome of Breast Cancers Diagnosed in BRCA1 and BRCA2 Gene Mutation Carriers in Intensive Screening Programs Including Magnetic Resonance Imaging.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 113
- By:
- Publication type:
- Article
6
Does Tumor Size Trump Biology?
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 111, doi. 10.3816/CBC.2010.n.015
- By:
- Publication type:
- Article
7
Rheumatic Disorders and Functional Disability With Aromatase Inhibitor Therapy.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 144, doi. 10.3816/CBC.2010.n.019
- By:
- Publication type:
- Article
8
A Phase II Trial of Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer Who Have Received Prior Taxane Therapy.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 148, doi. 10.3816/CBC.2010.n.020
- By:
- Publication type:
- Article
9
Selected Phase III Trials in Recurrent/Metastatic Breast Cancer Conducted in the United States.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 164, doi. 10.1016/S1526-8209(11)70025-8
- By:
- Publication type:
- Article
10
Evolution of Capecitabine Dosing in Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 130, doi. 10.3816/CBC.2010.n.017
- By:
- Publication type:
- Article
11
Breast Cancer Hormone Receptor Assay Results of Core Needle Biopsy and Modified Radical Mastectomy Specimens From the Same Patients.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 154, doi. 10.3816/CBC.2010.n.021
- By:
- Publication type:
- Article
12
Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 160, doi. 10.3816/CBC.2010.n.023
- By:
- Publication type:
- Article
13
Oncologists' Recommendations for Adjuvant Therapy in Hormone Receptor–Positive Breast Cancer Patients of Varying Age and Health Status.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 2, p. 136, doi. 10.3816/CBC.2010.n.018
- By:
- Publication type:
- Article